Clinical Senior Lecturer in Medical Oncology
Increased early phase trials activity in solid tumour oncology has been identified as a strategic priority in Division of Cancer and Department of Surgery and Cancer. Success of the CRUK Centre, ECMC and BRC renewals is predicated upon increasing the portfolio of early phase trials in cancer – particularly as a conduit for clinical translation of scientific discoveries within the Centre but also to ensure that we establish a broad portfolio...
Job listing information
- Reference MED00829
- Date posted 23 October 2018
- Closing date 23 November 2018
Increased early phase trials activity in solid tumour oncology has been identified as a strategic priority in Division of Cancer and Department of Surgery and Cancer.
Success of the CRUK Centre, ECMC and BRC renewals is predicated upon increasing the portfolio of early phase trials in cancer – particularly as a conduit for clinical translation of scientific discoveries within the Centre but also to ensure that we establish a broad portfolio of clinical trials ranging from phase I to phase III to offer patients. There is also a developing pipeline of new anti-cancer drugs emerging from Imperial, exemplified by the first-in-class CDK7 inhibitor ICEC-0942 (CT7001), and it is imperative that we are able to take these studies into phase I trial at Imperial.
The successful candidate will play a critical role in achieving Departmental and Divisional goals for early clinical trials expansion – and of meeting goals set out in ECMC, CRUK centre and BRC cancer theme renewals.
Duties and responsibilities
The post holder is expected to act as Principal and Chief Investigator in early phase (especially phase IB and IIA) clinical trials across solid tumour oncology as well as have a disease-specific interest. There is no mandated tumour-specific interest, but alignments with the Division’s main cancer areas (prostate, breast, gynaecological and hepatopancreatobiliary malignancies) is strongly preferred. Close working with the NIHR/Wellcome Trust Clinical Research Facility (Director Professor Martin Wilkins) will be essential for early phase trial delivery.
This role will also facilitate the clinical translation of preclinical research. The post holder will co-supervise PhD students and clinical research fellows with non-clinical researchers. In addition, the post holder will have a disease-specific interest (preferably in prostate, breast, gynaecological and hepatopancreatobiliary malignancies), and thus should link specifically with the research teams working within those cancer fields.
The post holder will develop partnerships with the pharmaceutical industry, to bring novel agents and novel clinical trials to Imperial College and enhance its reputation and build a critical mass of early phase studies.
The post holder is expected to generate research income from clinical trials – largely industry-sponsored, but also funded from clinical trials grants from Cancer Research UK, MRC, NIHR and other academic grant-funders.
Applicants must demonstrate how they meet the essential criteria required of the post but in particular, must have GMC registration, appropriate specialist qualification, a national and developing international reputation in their field of research, experience and capabilities to act as a role model in areas of research, teaching and management and excellent leadership skills. In addition, applicants are expected to have attained experience of teaching undergraduate and postgraduate students, be able to communicate effectively and have extensive experience in medical oncology.
This post is full time and fixed term for 5 years in the first instance.
Should you have any queries please contact:
Professor Iain McNeish - firstname.lastname@example.org
Further information about the Department of Surgery & Cancer can be located here: http://www.imperial.ac.uk/department-surgery-cancer/
About Imperial College London
Imperial College London is the UK’s only university focussed entirely on science, engineering, medicine and business and we are consistently rated in the top 10 universities in the world.
You will find our main London campus in South Kensington, with our hospital campuses located nearby in West and North London. We also have Silwood Park in Berkshire and state-of-the-art facilities in development at our major new campus in White City.
We work in a multidisciplinary and diverse community for education, research, translation and commercialisation, harnessing science and innovation to tackle the big global challenges our complex world faces.
It’s our mission to achieve enduring excellence in all that we do for the benefit of society – and we are looking for the most talented people to help us get there.
Please note that job descriptions cannot be exhaustive and the post-holder may be required to undertake other duties, which are broadly in line with the above key responsibilities.
All Imperial employees are expected to follow the 7 principles of Imperial Expectations:
- Champion a positive approach to change and opportunity
- Communicate regularly and effectively within, and across, teams
- Consider the thoughts and expectations of others
- Deliver positive outcomes
- Encourage inclusive participation and eliminate discrimination
- Develop and grow skills and expertise
- Work in a planned and managed way
In addition to the above, employees are required to observe and comply with all College policies and regulations.
Imperial College is committed to equality of opportunity, to eliminating discrimination and to creating an inclusive working environment. We are an Athena SWAN Silver award winner, a Stonewall Diversity Champion, a Disability Confident Employer and work in partnership with GIRES to promote respect for trans people.
Athena SWAN Silver Award 2016
We renewed our Silver in the April 2016 submission round. Recognising advancement of gender equality.